What is the price of 3D Global Biotech Inc. (6808)

The price of 3D Global Biotech Inc. (6808) is $1.16

What is the market cap of 3D Global Biotech Inc. (6808)

The market cap of 3D Global Biotech Inc. (6808) is $89.35M

3D Global Biotech Inc. (6808) Price History

Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.

Year	Performance
2026 (TTM)	-14.91%
2025	3.60%
2024	135.77%
2023	-29.72%
2022	-37.06%
2021	-19.88%
2020	0.00%

Year

Performance

2026 (TTM)

-14.91%

2025

3.60%

2024

135.77%

2023

-29.72%

2022

-37.06%

2021

-19.88%

2020

0.00%

Company	Stock price	Change 1y%	Country
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$118.70	-15.60%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

Company

Stock price

Change 1y%

Country